Efficacy and safety of monotherapy and combination therapy of immune checkpoint inhibitors as first-line treatment for unresectable hepatocellular carcinoma: a systematic review, meta-analysis and network meta-analysis

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the cancers with the highest morbidity and mortality. Sorafenib used to be the main treatment for unresectable HCC patients. However, regimens based on immune checkpoint inhibitors (ICIs) have attracted attention in recent years because of their r...

Descripción completa

Detalles Bibliográficos
Autores principales: Lei, Qing, Yan, Xin, Zou, Huimin, Jiang, Yixuan, Lai, Yunfeng, Ung, Carolina Oi Lam, Hu, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519826/
https://www.ncbi.nlm.nih.gov/pubmed/36171533
http://dx.doi.org/10.1007/s12672-022-00559-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519826/
https://www.ncbi.nlm.nih.gov/pubmed/36171533
http://dx.doi.org/10.1007/s12672-022-00559-1

Ejemplares similares